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LETTERS TO THE EDITOR
Patients With High-Risk
Acute Myocardial Infarction Randomized
to One of Two Treatment
Strategies: Delay and Eligibility Questions
Grines et al. (1) reported randomization of patients with high-risk
acute myocardial infarction (AMI) to one of two treatment
strategies, namely transfer for primary percutaneous transluminal
coronary angioplasty (PTCA) or on-site thrombolysis. Random-
ization required a mean of 44 min (median 32 min) and resulted in
a mean delay of 63 min (median 51 min) from emergency room
arrival to delivery of thrombolytic treatment. The time from
symptom onset to emergency room arrival was not presented. This
time interval is important for judging the impact of the reported
treatment delay on mortality (2).
In addition, it would be interesting to know the proportion of
patients eligible for the study, that is, the numbers of AMI patients
screened, number of patients matching high-risk criteria, and
number of those excluded.
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Safety and Benefits of Transferring
Patients With Acute Myocardial
Infarction to Interventional
Center for Immediate Angioplasty
The study by Grines et al. (1), which appeared recently in JACC,
evaluated the safety and benefits of transfer of a high-risk patient
suffering an acute myocardial infarction (AMI) to a regional
interventional center for immediate angioplasty. The investigators
concluded: “This trial demonstrated that patients with high-risk
AMI at hospitals without percutaneous transluminal coronary
angioplasty (PTCA) capabilities might have an improved outcome
if transferred for emergency PTCA rather than being treated with
thrombolytic therapy.” In the editorial (2) that accompanied the
study, Cannon and Baim stated “it appears that there may be
benefit in prompt and efficient transfer of patients from a com-
munity hospital that does not offer primary percutaneous coronary
intervention (PCI) to a nearby one that does.” This begs an
important question concerning the safety of transferring a patient
with AMI. The investigators note that their study is underpowered
to answer the question. The difficulty in recruitment of subjects
and premature closure of the study suggest that the study group is
a highly selective set of patients. Before the availability of imme-
diate angioplasty it was believed that transfer was inappropriate for
the AMI patient. This patient is at the greatest danger for
extension of the infarction, serious arrhythmia, and congestive
heart failure in the first hours after the infarction. Monitoring for
and managing these complications are very difficult when the
patient is transferring from one hospital to another.
Cannon and Baim (2) noted that success for PCI is related to
the skill and experience of the interventionalist. Many hospitals
with catherization laboratories have the availability of high-volume
interventionalists. However, the majority of these physicians are
unwilling to perform interventions at hospitals that do not rou-
tinely perform angioplasty. Because it is not a routine procedure,
PTCA performed under emergency circumstances would represent
a higher risk for the patient. As a solution to this problem, Cannon
and Baim suggested a network of cardiac centers offering PCI
around the clock.
Could immediate angioplasty be safely and effectively applied at
the initial hospital? I believe that it is safer to bring the interven-
tion to the patient rather than the patient to the interventionalist.
For most patients with an AMI, this could be accomplished by
expanding PTCA to any hospital with a catheterization laboratory.
The use of routine PTCA at hospitals without back-up cardiovas-
cular surgery would significantly extend PCI to the at-risk popu-
lation and increase the availability of skilled interventionalists to
provide the service.
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REPLY
In response to correspondents Pechlaner and Bellmann, the time
from symptom onset to emergency room arrival was 140 46 min
in the transfer arm and 158 162 min in the lytic arm (p 0.40).
Unfortunately, screening logs were not maintained, and we were
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